Fulminant Central Nervous System Nocardiosis in a Patient Treated With Alemtuzumab for Relapsing-Remitting Multiple Sclerosis

JAMA Neurol. 2016 Jun 1;73(6):757-9. doi: 10.1001/jamaneurol.2016.0146.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alemtuzumab / therapeutic use*
  • Anti-Bacterial Agents / therapeutic use
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Central Nervous System Fungal Infections / complications*
  • Central Nervous System Fungal Infections / diagnostic imaging
  • Central Nervous System Fungal Infections / drug therapy
  • Female
  • Humans
  • Magnetic Resonance Imaging
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting* / complications
  • Multiple Sclerosis, Relapsing-Remitting* / diagnostic imaging
  • Multiple Sclerosis, Relapsing-Remitting* / drug therapy
  • Nocardia Infections / complications*
  • Nocardia Infections / drug therapy

Substances

  • Anti-Bacterial Agents
  • Antineoplastic Agents, Immunological
  • Alemtuzumab